Exclusive special offer and discount title banner vector image

GERMANY BIOPSY DEVICES MARKET FORECAST 2024-2032

SCOPE OF THE REPORT

Germany Biopsy Devices Market by Product (Needle-Based Biopsy Guns (Vacuum-Assisted Biopsy Devices, Fine Needle Aspiration Biopsy Devices, Core Needle Biopsy Devices), Biopsy Guidance Systems, Biopsy Needles, Biopsy Forceps, Other Products) Market by Application (Oncology, Gastroenterology, Pulmonology, Dermatology, Other Applications) Market by End Use (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers)


MARKET OVERVIEW

The Germany biopsy devices market is estimated to develop with a CAGR of 7.91% over the forecast period of 2024-2032 and is set to reach a revenue of $xx million by 2032

The Germany biopsy devices market is going through strategic growth, stimulated by the expanding applications of biopsy devices across various medical specialties. The versatility of these devices allows for their utilization in diverse fields, such as oncology, gastroenterology, and cardiology. This widening scope enhances the market’s significance, making biopsy devices integral tools for diagnostic and therapeutic purposes across multiple medical disciplines. As technology advances, biopsy devices continue to evolve, providing healthcare professionals with precise and efficient solutions for improved patient care and outcomes.

Further, the market is witnessing advancements in the development of cost-effective biopsy solutions. As the healthcare sphere in Germany seeks economically viable options without compromising quality, the demand for affordable yet efficient biopsy devices is on the rise. The development of cost-effective solutions not only addresses economic considerations but also promotes accessibility to biopsy procedures, making them more widely available to a diverse patient population. Hence, these factors are set to fuel the market’s growth in Germany during the forecast period.

Germany Biopsy Devices Market

To Know More About This Report, Request a Free Sample Copy

However, the growth of the market faces key restraints, such as the high risk of infection for patients. Invasive procedures like biopsies inherently carry a risk of infection, necessitating stringent protocols and adherence to hygiene standards in healthcare settings. Additionally, the high cost of biopsy procedures poses a challenge, limiting accessibility for certain patient demographics and healthcare facilities. 

Moreover, the market struggles with a shortage of skilled professionals, highlighting the importance of investing in training programs and educational initiatives to ensure a proficient workforce capable of performing accurate and safe biopsy procedures. Addressing these restraints is crucial for sustaining the positive momentum in the Germany biopsy devices market and optimizing the benefits of expanding applications and cost-effective solutions.

The Germany biopsy devices market segmentation includes product, application, and end use. The application segment incorporates oncology, gastroenterology, pulmonology, dermatology, and other applications. Pulmonology applications are essential tools for diagnosing and monitoring lung-related conditions. These devices enable healthcare professionals to obtain tissue samples from the lungs, aiding in the accurate identification of diseases such as lung cancer, infections, and inflammatory disorders. As the field of pulmonology continues to advance, biopsy devices contribute significantly to improving diagnostic precision, ultimately leading to more effective treatment strategies and enhanced patient outcomes.

Simultaneously, the dermatology sub-segment showcases the versatility of biopsy devices in addressing diverse medical needs. In dermatology, biopsy devices are important for obtaining skin tissue samples and facilitating the diagnosis of various skin conditions, including melanoma, dermatitis, and other skin cancers. 

Moreover, the precise nature of biopsy procedures in dermatology contributes to early detection and customized treatment plans, underscoring the importance of biopsy devices in maintaining skin health. As dermatological research and practices evolve, biopsy devices continue to be integral tools for dermatologists, ensuring accurate diagnoses and optimal patient care. 

Some of the leading players in the Germany biopsy devices market are Cardinal Health, Boston Scientific, DTR Medical, Danaher Corporation, etc. 

Cardinal Foods later renamed Cardinal Health in 1979, the company is headquartered in Dublin, Ohio. With a global presence, including Germany, it focuses exclusively on healthcare distribution after divesting its food division in 1987. Specializing in pharmaceutical and medical-surgical products, the company offers retail and mail-order facilities for pharmaceuticals and surgical solutions. Cardinal Health is known for automated replenishment services, optimizing the supply chain for surgical drapes, gloves, and minimally invasive devices.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2024-2032
Base Year2023
Market Historical Years2018-2022
Forecast UnitsRevenue ($ Million) 
Segments Analyzed
Product, Application, and End Use
Countries AnalyzedGermany
Companies AnalyzedCardinal Health, Hologic Inc, Danaher Corporation, Conmed Corporation, Cook Medical, DTR Medical, Inrad Inc, Boston Scientific, Medtronic PLC, Becton Dickinson and Company
TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. COUNTRY SNAPSHOT
    3. COUNTRY ANALYSIS
    4. SCOPE OF STUDY
    5. CRISIS SCENARIO ANALYSIS
      1. IMPACT OF COVID-19 ON BIOPSY DEVICES MARKET
    6. MAJOR MARKET FINDINGS
      1. GROWING EMPHASIS ON PERSONALIZED MEDICINE
      2. EXPANDING APPLICATIONS ACROSS MEDICAL SPECIALITIES
      3. DEVELOPMENT OF COST-EFFECTIVE BIOPSY SOLUTIONS
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. RISING PREVALENCE OF CANCER
      2. INCREASING DEMAND FOR MINIMALLY INVASIVE SURGERIES
      3. SURGE IN THE NUMBER OF HOSPITALS AND DIAGNOSTIC CENTERS
    2. KEY RESTRAINTS
      1. HIGH RISK OF INFECTION FOR PATIENTS
      2. HIGH COST OF BIOPSY PROCEDURES
      3. LACK OF SKILLED PROFESSIONALS
  4. KEY ANALYTICS
    1. KEY MARKET TRENDS
      1. SURGE IN THE HEALTHCARE EXPENDITURE
      2. SHIFT TOWARDS PREVENTIVE HEALTHCARE
      3. ADVANCEMENTS IN BIOPSY TECHNOLOGY
    2. PESTLE ANALYSIS
    3. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTIONS
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    4. VALUE CHAIN ANALYSIS
      1. RAW MATERIALS
      2. MANUFACTURERS
      3. DISTRIBUTION
      4. END-USERS
  5. MARKET BY PRODUCT
    1. NEEDLE- BASED BIOPSY GUNS
      1. VACUUM-ASSISTED BIOPSY (VAB) DEVICES
      2. FINE NEEDLE ASPIRATION BIOPSY (FNAB) DEVICES
      3. CORE NEEDLE BIOPSY (CNB) DEVICES
    2. BIOPSY GUIDANCE SYSTEMS
    3. BIOPSY NEEDLES
    4. BIOPSY FORCEPS
    5. OTHER PRODUCTS
  6. MARKET BY APPLICATION
    1. ONCOLOGY
    2. GASTROENTEROLOGY
    3. PULMONOLOGY
    4. DERMATOLOGY
    5. OTHER APPLICATIONS
  7. MARKET BY END USE
    1. HOSPITALS
    2. AMBULATORY SURGICAL CENTERS
    3. DIAGNOSTIC CENTERS
  8. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
      4. BUSINESS EXPANSIONS & DIVESTITURES
    2. COMPANY PROFILES
      1. CARDINAL HEALTH
      2. HOLOGIC INC
      3. DANAHER CORPORATION
      4. CONMED CORPORATION
      5. COOK MEDICAL
      6. DTR MEDICAL
      7. INRAD INC
      8. BOSTON SCIENTIFIC
      9. MEDTRONIC PLC
      10. BECTON DICKINSON AND COMPANY

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – BIOPSY DEVICES

TABLE 2: GERMANY BIOPSY DEVICES MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 3: GERMANY BIOPSY DEVICES MARKET, BY PRODUCT, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 4: GERMANY BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY GUNS, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 5: GERMANY BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY GUNS, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 6: GERMANY BIOPSY DEVICES MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 7: GERMANY BIOPSY DEVICES MARKET, BY APPLICATION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 8: GERMANY BIOPSY DEVICES MARKET, BY END USE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 9: GERMANY BIOPSY DEVICES MARKET, BY END USE, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 10: LIST OF MERGERS & ACQUISITIONS

TABLE 11: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 12: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 13: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: VALUE CHAIN ANALYSIS

FIGURE 4: GERMANY BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2023

FIGURE 5: GERMANY BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY GUNS, 2024-2032 (IN $ MILLION)

FIGURE 6: GERMANY BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY NEEDLE-BASED BIOPSY GUNS, IN 2023

FIGURE 7: GERMANY BIOPSY DEVICES MARKET, BY VACUUM-ASSISTED BIOPSY (VAB) DEVICES, 2024-2032 (IN $ MILLION)

FIGURE 8: GERMANY BIOPSY DEVICES MARKET, BY FINE NEEDLE ASPIRATION BIOPSY (FNAB) DEVICES, 2024-2032 (IN $ MILLION)

FIGURE 9: GERMANY BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY (CNB) DEVICES, 2024-2032 (IN $ MILLION)

FIGURE 10: GERMANY BIOPSY DEVICES MARKET, BY BIOPSY GUIDANCE SYSTEMS, 2024-2032 (IN $ MILLION)

FIGURE 11: GERMANY BIOPSY DEVICES MARKET, BY BIOPSY NEEDLES, 2024-2032 (IN $ MILLION)

FIGURE 12: GERMANY BIOPSY DEVICES MARKET, BY BIOPSY FORCEPS, 2024-2032 (IN $ MILLION)

FIGURE 13: GERMANY BIOPSY DEVICES MARKET, BY OTHER PRODUCTS, 2024-2032 (IN $ MILLION)

FIGURE 14: GERMANY BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2023

FIGURE 15: GERMANY BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2032 (IN $ MILLION)

FIGURE 16: GERMANY BIOPSY DEVICES MARKET, BY GASTROENTEROLOGY, 2024-2032 (IN $ MILLION)

FIGURE 17: GERMANY BIOPSY DEVICES MARKET, BY PULMONOLOGY, 2024-2032 (IN $ MILLION)

FIGURE 18: GERMANY BIOPSY DEVICES MARKET, BY DERMATOLOGY, 2024-2032 (IN $ MILLION)

FIGURE 19: GERMANY BIOPSY DEVICES MARKET, BY OTHER APPLICATIONS, 2024-2032 (IN $ MILLION)

FIGURE 20: GERMANY BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY END USE, IN 2023

FIGURE 21: GERMANY BIOPSY DEVICES MARKET, BY HOSPITALS, 2024-2032 (IN $ MILLION)

FIGURE 22: GERMANY BIOPSY DEVICES MARKET, BY AMBULATORY SURGICAL CENTERS, 2024-2032 (IN $ MILLION)

FIGURE 23: GERMANY BIOPSY DEVICES MARKET, BY DIAGNOSTIC CENTERS, 2024-2032 (IN $ MILLION)

FAQ’s